Durvalumab-induced thyroiditis in a patient with non-small cell lung carcinoma: a case report and review of pathogenic mechanisms

por de Filette, Jeroen M. K., André, Stéphanie, De Mey, Lynn, Aspeslagh, Sandrine, Karmali, Rafik, Van der Auwera, Bart J, Bravenboer, Bert
Publicado 2022

CTLA4, SH2B3, and CLEC16A diversely affect the progression of early islet autoimmunity in relatives of Type 1 diabetes patients

por Vandewalle, Julie, Desouter, Aster K, Van der Auwera, Bart J, Tenoutasse, Sylvie, Gillard, Pieter, De Block, Christophe, Keymeulen, Bart, Gorus, Frans K, Van de Casteele, Mark
Publicado 2023

Genetic variation at ERBB3/IKZF4 and sexual dimorphism in epitope spreading in single autoantibody-positive relatives

por Vandewalle, Julie, Van der Auwera, Bart J., Amin, Henna, Quartier, Erik, Desouter, Aster K., Tenoutasse, Sylvie, Gillard, Pieter, De Block, Christophe, Keymeulen, Bart, Gorus, Frans K., Van de Casteele, Mark
Publicado 2021

Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review

por de Filette, Jeroen M K, Pen, Joeri J, Decoster, Lore, Vissers, Thomas, Bravenboer, Bert, Van der Auwera, Bart J, Gorus, Frans K, Roep, Bart O, Aspeslagh, Sandrine, Neyns, Bart, Velkeniers, Brigitte, Kharagjitsingh, Aan V
Publicado 2019

HLA-A*24 Is an Independent Predictor of 5-Year Progression to Diabetes in Autoantibody-Positive First-Degree Relatives of Type 1 Diabetic Patients

por Mbunwe, Eric, Van der Auwera, Bart J., Vermeulen, Ilse, Demeester, Simke, Van Dalem, Annelien, Balti, Eric V., Van Aken, Sara, Derdelinckx, Luc, Dorchy, Harry, De Schepper, Jean, van Schravendijk, Chris, Wenzlau, Janet M., Hutton, John C., Pipeleers, Daniël, Weets, Ilse, Gorus, Frans K.
Publicado 2013